The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study
Sign Up to like & getrecommendations! Published in 2022 at "BMC Endocrine Disorders"
DOI: 10.1186/s12902-022-01009-3
Abstract: Background Recently, side effects from Dopamine Receptor Agonist Drugs (DAs) in treating pituitary prolactinoma have raised widespread concern. This study explores the incidence and influencing factors of DAs-related side effects in Chinese prolactinoma patients. Methods… read more here.
Keywords: side effects; chinese prolactinoma; prolactinoma; study ... See more keywords